Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. RD10083917

IL-13 Antibody [Alexa Fluor™ Plus 594] - Humanized, (Research Grade anrukinzumab Biosimilar), Novus Biologicals™
SDP

Catalog No. RD10083917
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
RD10083917 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. RD10083917 Supplier R&D Systems Supplier No. NBP328289AFP594

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

Description

Human Monoclonal Antibody

IL-13 Monoclonal antibody specifically detects IL-13 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay

Specifications

Antigen IL-13
Applications Flow Cytometry, ELISA, Functional Assay
Classification Monoclonal
Conjugate Alexa Fluor Plus 594
Formulation 50mM Sodium Borate
Gene Alias ALRHMGC116789, BHR1interleukin-13, IL-13MGC116788, interleukin 13, MGC116786, NC30, P600
Host Species Human
Immunogen IL-13
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Asthma, Biologically Active Proteins, Cancer, Cytokine Research, Immunology, Innate Immunity
Primary or Secondary Primary
Gene ID (Entrez) 3596
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.